TALAROMYCOSIS
Clinical trials for TALAROMYCOSIS explained in plain language.
Never miss a new study
Get alerted when new TALAROMYCOSIS trials appear
Sign up with your email to follow new studies for TALAROMYCOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug wake up immune cells to beat HIV-Related infections?
Disease control Not yet recruitingThis study tests a drug called Sintilimab, which is normally used for cancer, to see if it can help people with HIV who have infections that won't go away with standard treatment. The drug works by 'waking up' exhausted immune cells. Fifty adults with HIV and a hard-to-treat infe…
Matched conditions: TALAROMYCOSIS
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for HIV patients: shorter, stronger fungal infection treatment on trial
Disease control Not yet recruitingThis study tests two new ways to treat talaromycosis, a serious fungal infection in people with HIV. It compares a single high dose of a newer antifungal drug (liposomal amphotericin B) against two weeks of the standard drug, and also checks if adding another medicine (flucytosin…
Matched conditions: TALAROMYCOSIS
Phase: PHASE3 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC